Immuno-oncology therapy developer Century Therapeutics has emerged from stealth, having raised $250m from Leaps by Bayer, which invested $215m, and Fujifilm subsidiary FCDI.

Leaps by Bayer, an investment vehicle for pharmaceuticals and chemicals producer Bayer, invested $215m to lead a $250m funding round for US-based immuno-oncology drug developer Century Therapeutics yesterday. Fujifilm Cellular Dynamics (FCDI), a biotech-focused subsidiary of imaging technology producer Fujifilm, also participated in the round, as did venture capital firm Versant Ventures. Founded in 2018…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.